Day: November 27, 2020
– R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable therapeutic for COVID-19 –– Q3 2020 sales of $3,476,000 compared to $2,908,000 for Q3 2019, representing a 20% increase –– Net profit of $192,000 for Q3 2020 vs. net loss of $104,000 for Q3 2019 –– Cash generated from operations of $4,777,000 in 2020 vs. $1,321,000 in 2019 –– Maintained production operations during COVID-19 pandemic and completed integration of manufacturing sites –EDMONTON, Alberta, Nov. 27, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational...
Global Ship Lease Announces Mandatory Partial Redemption of 9.875% First Priority Secured Notes Due 2022
Written by Customer Service on . Posted in Public Companies.
LONDON, Nov. 27, 2020 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company”) today announced that it has sent notice of mandatory partial redemption of its 9.875% First Priority Secured Notes due 2022 (the “Notes”) to holders of the Notes. The Company is mandatorily redeeming (the “Mandatory Partial Redemption”) of $28,000,000 aggregate principal amount of the Notes (the “Redeemed Notes”) at a redemption price equal to 102.00% of the principal amount thereof (the “Redemption Price”) plus accrued and unpaid interest to, but not including, the redemption date of December 7, 2020 (the “Redemption Date”). The Mandatory Partial Redemption is being made pursuant to requirements set forth in the indenture governing the Notes that requires the Company to redeem Notes.The Redeemed Notes will be selected by Citibank, N.A., London...
USAN Modifies Lead Drug Candidate’s Chemical Name to ‘Simufilam’
Written by Customer Service on . Posted in Public Companies.
AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the World Health Organization (WHO) advised the United States Adopted Names Council (USAN) to modify the chemical name of the Company’s lead drug candidate to ‘simufilam.’ This change was advised by WHO to avoid a potential trademark conflict with a drug marketed in the Far East.USAN has accepted WHO’s advice. Future references to Cassava Sciences’ lead drug candidate for Alzheimer’s disease will be simufilam.About USANThe United States Adopted Names Council is responsible for selecting simple, informative and unique nonproprietary drug names. The USAN Council establishes logical nomenclature classifications based on pharmacological or chemical relationships. In addition to one member-at-large and a U.S. Food and Drug Administration...
SuRo Capital Corp. Provides Mid-Quarter Update
Written by Customer Service on . Posted in Public Companies.
Currently Holds 80% Of Its Pre-IPO Palantir Holdings, Consistent with Lock-Up AgreementAnticipates Declaring Additional Dividend By Year-EndSAN FRANCISCO, Nov. 27, 2020 (GLOBE NEWSWIRE) — SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today issued the following statement to provide additional clarity regarding its current investment in Palantir Technologies, Inc. (“Palantir”):“We currently hold 4,618,952 restricted common shares of Palantir. This is consistent with the Palantir lock-up agreement, reflecting 80% of our pre-IPO holdings of 5,773,690 common shares,” said Mark Klein, President and Chief Executive Officer of SuRo Capital. “At the end of the third quarter, we held 5,373,690 common shares of Palantir, inclusive of 754,738 remaining unrestricted common shares. As reported in our...
Saint Jean Carbon Announces $122,500 Private Placement
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESOAKVILLE, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) — Saint Jean Carbon Inc. (“Saint Jean” or the “Company”) (TSX-V: SJL) is pleased to announce that it intends to complete a non-brokered private placement financing of up to 3,500,000 common shares in the capital of the Company (the “Shares”) at a price of $0.035 per Share for gross proceeds of up to $122,500 (the “Offering”). The Shares are subject to a four month and one (1) day hold period.The Company intends to use the proceeds of the Offering to preserve the Company’s existing operations and for general corporate and administrative purposes. The breakdown of the intended use of proceeds for the ensuing 6-month period is shown in the table below:Although the Company intends to use the proceeds...
Tallink Silja OY signs loan agreement with Nordic Investment Bank
Written by Customer Service on . Posted in Public Companies.
Tallink Silja OY, a subsidiary of AS Tallink Grupp, and Nordic Investment Bank (“NIB”) have today signed a term loan agreement for financing of working capital. The total amount of the loan limit is EUR 100 million and the loan can be drawn in EUR 10-40 million disbursements. The loan is secured by the mortgages on the consolidation group’s vessels Megastar and Baltic Queen, ranking after the existing creditors and the corporate guarantee of AS Tallink Grupp. The Government of the Republic of Finland has issued a state guarantee in favour of NIB regarding the loan facility covering 90% of the outstanding principal amount of the loan.The loan carries Euribor based floating interest rate and has final maturity of four years. The repayment of the loan starts in two years from the signing of the agreement.As a result of the transaction,...
Tallink Silja OY allkirjastas laenulepingu Põhjamaade Investeerimispangaga
Written by Customer Service on . Posted in Public Companies.
AS Tallink Grupp tütarettevõte Tallink Silja OY ja Põhjamaade Investeerimispank (Nordic Investment Bank, “NIB”) allkirjastasid täna käibekapitali laenulepingu. Laenulimiidi ulatus on 100 miljonit eurot ning laen on lubatud kasutusse võtta 10-40 miljoni euro suuruste osade kaupa.Laenu tagatiseks on hüpoteegid konsolideerimisgruppi kuuluvate laevade Megastar ja Baltic Queen olemasolevate kreeditoride taga olevale järjekohtadele ja AS-i Tallink Grupp garantii. Soome Vabariigi valitsus on andnud NIB kasuks riigipoolse garantii, mis katab 90% kasutuses olevast laenu põhiosast.Laen kannab Euriboril baseeruvat muutuvat intressimäära ja on tagasimaksete lõpptähtajaga neli aastat. Laenu tagasimaksed algavad kahe aasta pärast alates laenulepingu sõlmimisest.Sõlmitud laenuleping tugevdab Tallink Silja OY, ja seeläbi kogu konsolideerimisgrupi...
Tallink Silja OY signs loan agreement with Nordic Investment Bank
Written by Customer Service on . Posted in Public Companies.
Tallink Silja OY, a subsidiary of AS Tallink Grupp, and Nordic Investment Bank (“NIB”) have today signed a term loan agreement for financing of working capital. The total amount of the loan limit is EUR 100 million and the loan can be drawn in EUR 10-40 million disbursements. The loan is secured by the mortgages on the consolidation group’s vessels Megastar and Baltic Queen, ranking after the existing creditors and the corporate guarantee of AS Tallink Grupp. The Government of the Republic of Finland has issued a state guarantee in favour of NIB regarding the loan facility covering 90% of the outstanding principal amount of the loan.The loan carries Euribor based floating interest rate and has final maturity of four years. The repayment of the loan starts in two years from the signing of the agreement.As a result of the transaction,...
Fynske Bank A/S: Storaktionærmeddelelse
Written by Customer Service on . Posted in Public Companies.
Selskabsmeddelelse nr. 2020/16Strategic Investments A/S oplyser i medfør af § 29 i Lov om Værdipapirhandel, at selskabet den 27. november 2020 har erhvervet yderligere 6.837 stk. aktier i Fynske Bank A/S. Selskabets samlede aktie-besiddelse udgør herefter i alt 760.000 stk., svarende til 10,03% af aktiekapitalen.For yderligere information, kontakt venligst:Adm. direktør Petter Blondeau, tlf. 6217 6501 eller 6168 0501.Med venlig hilsenFynske Bank A/SVedhæftet filSelskabsmeddelelse 2020-16
DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies
Written by Customer Service on . Posted in Public Companies.
Initial funding of up to $34 million for the project “Gene Mabs: A Scalable, Economic, Gene-Encoded Protective Antibody Platform Against Coronavirus” (HR0011-21-9-0015) to support the development of an STI-2020-encoded Gene MAbTM through Phase 2 clinical studies.STI-2020-encoded Gene MAb is in development for intramuscular injection against the SARS-CoV-2 virus and its variant strains to produce potent STI-2020 nAbs in the body.STI-2020-encoded Gene MAb products can potentially be stored at refrigerator temperatures, avoiding some of the cold chain management challenges associated with the deployment of COVID-19 vaccines currently in development. Sorrento has a cGMP facility in place to meet initial production demand and Sorrento expects that STI-2020-encoded Gene MAb can be produced in large quantity to meet potentially high demand.SAN...